Your Doorway to Japan

JAPAN LIFE CULTURE TRAVEL INSIGHT

日本語
简体字
繁體字
Français
Español
العربية
Русский

Welcome to the New Nippon.com

Japan Life
JAPAN LIFE
Japan’s Culture
CULTURE
- Japan’s Culture
- Manga/Anime
- Arts
- Entertainment
- History
- Sports
- Sci/Tech
- Language
Travel in Japan
TRAVEL
Insight on Japan
INSIGHT
ARTICLE TYPE
- JAPAN DATA
- PHOTOS
- VIDEO
- PEOPLE
- COLUMN
- BLOG
- ANNOUNCEMENTS
NEWS

About Nippon.com

The Nippon Communications Foundation produces Nippon.com to bring you Japan in your language.

ABOUT US

Newsletter

Click for information on our weekly email newsletter.

SUBSCRIBE

Home
>Opdivo

Opdivo

LATEST

Spotlight on New Cancer Immunotherapy: Ono Pharmaceutical’s OpdivoINSIGHT | Feb 9, 2016

MOST POPULAR

1
Miyazaki Hayao’s Animism: The Historical Theories That Shaped “Princess Mononoke” CULTURE | Oct 20, 2026
2
A Short History of Studio Ghibli: Four Decades of Anime Classics CULTURE | Oct 20, 2026
3
Nara’s Three-Faced Ashura: The Resolute, Sorrowful Gazes of a Kōfukuji Masterpiece CULTURE | Oct 27, 2026
4
“Otsukare Sama Desu”: A Daily Greeting in Japanese Workplaces JAPAN LIFE | Oct 14, 2026
5
Making It Through: Considering Iran’s Decision to Let a Japanese Tanker Pass Hormuz INSIGHT | Oct 24, 2026

Welcome to the New Nippon.com
Announcing the “Moments in Japan” Photo Contest Winners
“Moments in Japan”: Nippon.com Kicks Off Photo Contest with Tokyo Camera Club

Our Newsletter SUBSCRIBE

Follow Us

SECTION

Japan Life

Daily Life
Food and Drink
Traditions
Health
Education
Disaster
Japan Glances

Japan’s Culture

Manga/Anime
Arts
Entertainment
History
Sports
Sci/Tech
Language

Travel in Japan

Seasons
Destinations
Experiences
Festivals
Events
Japanscapes
Basic Info

Insight on Japan

Politics
Economy
Society
Diplomacy
Imperial Family

NEWS

ARTICLE TYPE

JAPAN DATA
PHOTOS
VIDEO
PEOPLE
COLUMN
BLOG
ANNOUNCEMENTS

Copyright
Privacy Policy
Social Media Policy
Contact

©2011-2026 Nippon Communications Foundation